首页> 外文期刊>human mutation >Illegitimate transcription: Its use in the study of inherited disease
【24h】

Illegitimate transcription: Its use in the study of inherited disease

机译:Illegitimate transcription: Its use in the study of inherited disease

获取原文
           

摘要

AbstractIn 1988, by using the powerful and accurate cDNA/PCR technique, it was demonstrated that there are very low levels of dystrophin mRNA in a variety of non‐muscle tissues, including cultured fibroblasts and lymphoblastoid cell lines. The phenomenon was also shown for a number of other tissue‐specific genes, including β‐globin, factors VIIIc and IX, anti‐Müllerian hormone, L‐pyruvate kinase, retinal blue pigment, phenylalanine hydroxylase. The level of transcript in inappropriate cells is exceedingly low, perhaps one mRNA per 100–1000 cells. This low‐level ubiquitous transcription of tissue‐specific genes was called “illegitimate” or “ectopic” transcription, and has been proven to occur for 17 gene transcripts to date. The mechanism and biological significance of illegitimate transcription are still obscure, but, since illegitimate transcripts exhibit the same pathology as legitimate transcripts, they have been useful tool in the study of already 9 inherited diseases. This strategy will be applied widely for diseases where samples from the appropriate tissue for study is difficult to obtain, or where an mRNA is easier or more informative to study than a genomic DNA (as for large genes, or where alternative splicing is involved

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号